Regeneron Pharmaceuticals
REGN
NASDAQ
IPO1991
about REGN
Regeneron Pharmaceuticals is a leading biopharmaceutical company focused on researching, developing, and producing innovative medicines and genetic-based treatments, including its widely used treatment for eye diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $555.21 | $560.00 | $552.98 | $59.19B | 872.19K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$13.24 | 12.87 | 16.74 | 29.37% | 37.86% | 0.62% |